Streetbeat News

Stock Prices

T

A significant bullish stance has been taken on AT&T (NYSE:T) by a large investor or institution, as indicated by unusual options activity. The sentiment among these big-money traders is split 50% bullish and 50% bearish. The whales have been targeting a price range from $13.0 to $16.0 for AT&T over the last 3 months. Citigroup has upgraded AT&T to Buy with a price target of $17.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:34 pm

CCI

Crown Castle (NYSE:CCI) has outperformed the market over the past 20 years by 4.64% on an annualized basis, producing an average annual return of 12.21%. If an investor had bought $1000 of CCI stock 20 years ago, it would be worth $10,310.74 today.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:30 pm

LIN

Over the past 10 years, Linde (NYSE:LIN) has outperformed the market by 2.26% on an annualized basis, producing an average annual return of 12.14%. If an investor had bought $1000 of LIN stock 10 years ago, it would be worth $3,120.75 today.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:30 pm

BTCUSD

President Joe Biden recently promoted a color-changing mug that reveals laser eyes, a popular meme among Bitcoin enthusiasts, when filled with hot liquid. This has led to speculation about whether Biden is warming up to Bitcoin. The timing of the tweet is notable, coming months after Biden proposed a 30% tax on crypto mining. The 2024 presidential election is over a year away, and Biden's potential embrace of Bitcoin could be a strategy to appeal to young voters and independents.

Portfolio Pulse from Murtuza Merchant

September 15, 2023 | 6:24 pm

COTY

EL

IPAR

D.A. Davidson analyst Linda Bolton Weiser reiterated a Buy rating on Inter Parfums Inc (IPAR) with an unchanged price target of $187. IPAR's fragrance segment is performing well globally, with Europe's recovery and Asia's growing luxury market contributing to the success. The company is optimistic about its 2024 sales guidance for Lacoste and Roberto Cavalli, transferred from Coty Inc (COTY), and the DKNY line, transferred from Estee Lauder Companies Inc (EL). The analyst raised 3Q23E sales and EPS to above consensus.

Portfolio Pulse from Shivani Kumaresan

September 15, 2023 | 6:06 pm

PTCT

The European Medicines Agency's Committee for Medicinal Products for Human Use has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of PTC Therapeutics Inc's Translarna for Duchenne muscular dystrophy. PTC plans to request a re-examination and the drug will remain on the market until the process is completed. Analysts from William Blair believe PTC has a chance to overturn the decision based on previous experience and positive data from studies.

Portfolio Pulse from Vandana Singh

September 15, 2023 | 6:05 pm

IOVA

The FDA has extended the review period for Iovance Biotherapeutics Inc's marketing application for lifileucel, a therapy for advanced melanoma. The new target action date is February 24, 2024. Despite the delay, analysts from HC Wainwright and Mizuho maintain their confidence in the approval of the therapy and reaffirm the Buy rating for IOVA stock. IOVA shares are up 18.30% at $5.49.

Portfolio Pulse from Vandana Singh

September 15, 2023 | 6:01 pm

AA

Over the past 3 months, 13 analysts have published their opinion on Alcoa (NYSE:AA) stock. The company has an average price target of $35.62, a decrease of 16.29% from the previous average price target of $42.55. The ratings range from bullish to somewhat bearish, with no bearish ratings.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

STZ

Over the past 3 months, 15 analysts have published their opinion on Constellation Brands (NYSE:STZ) stock. The average price target for the stock is $283.73, with a high of $305.00 and a low of $240.00. The average price target has increased by 6.92% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm

RHP

Ryman Hospitality Props (NYSE:RHP) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 1 somewhat bearish. The company has an average 12-month price target of $111.75, which has increased by 2.52% over the past month.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 6:00 pm